PeerCurrent.com|Stay current with the people and research shaping what comes next.

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Researcher

Hecheng Li

Ruijin Hospital

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines1

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · JOURNAL ARTICLE

The Adjuvant-Phase Dilemma After Neoadjuvant Chemoimmunotherapy in Resectable NSCLC: Evidence and Response-Guided Strategies

Cancers

A narrative review synthesizing evidence from phase III trials and biomarker studies to inform clinical decision-making about adjuvant immunotherapy after neoadjuvant chemoimmunotherapy in resectable NSCLC, without reporting original trial data or meta-analysis.

Expert GuidanceRadiomics and Machine Learning in Medical Imaging Hecheng Li Jingyuan Fan

Study details

DesignNarrative review

InterventionPostoperative immune checkpoint inhibitor t…

ComparatorOmission of adjuvant ICI, de-escalation str…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support